# Docosahexaenoic Acid (DHA) Administration and Length of Gestation: a Feasibility Study

> **NCT00691418** · NA · WITHDRAWN · sponsor: **Kaiser Permanente**

## Conditions studied

- Premature Birth

## Interventions

- **DIETARY_SUPPLEMENT:** docosahexaenoic acid (DHA)
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT00691418
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** decision made not to proceed -- no subjects were ever enrolled
- **Last updated:** 2015-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691418, "Docosahexaenoic Acid (DHA) Administration and Length of Gestation: a Feasibility Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00691418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*